Avtozma is part of the
Interleukin Antagonists class and treats
Juvenile Idiopathic Arthritis,
COVID-19 and
Rheumatoid Arthritis.
Interleukin antagonists are used to treat rheumatoid
arthritis,
psoriatic arthritis,
ulcerative colitis,
crohn's disease,
psoriasis and other
autoinflammatory syndromes. They work to reduce swelling and to suppress the immune system. Avtozma is only available as a brand name drug.